1.
Ntanasis-Stathopoulos I, Nikolaou P-E, Filippatos C, Miliotis M, Kostopoulos IV, Bakouros P, Makridakis M, Liacos C-I, Nikolopoulos K, Laidou S, Chatzidimitriou A, Frantzi M, Kastritis E, Fotiou D, Gavriatopoulou M, Vlahou A, Hatzigeorgiou AG, Tsitsilonis O, Dimopoulos MA, Terpos E. Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients. Haematologica; https://doi.org/10.3324/haematol.2026.301208 [Early view].